Literature DB >> 28969138

Gestational Trophoblastic Disease - Clinicopathological Study at Tertiary Care Hospital.

Sunil Vitthalrao Jagtap1, Vidhya Aher2, Suchi Gadhiya2, Swati Sunil Jagtap3.   

Abstract

INTRODUCTION: Gestational Trophoblastic Disease (GTD) is a term used for a group of pregnancy-related tumours. These consist of various tumours and tumour like lesions characterized by proliferation of trophoblastic tissue. Amongst GTD, hydatidiform moles are the most common form. These lesions sometimes may develop into invasive moles, or, in rare cases, into choriocarcinoma. AIM: To study the clinicopathologic characteristics and prevalence of different forms of gestational trophoblastic disease in a tertiary care hospital.
MATERIALS AND METHODS: The present study was descriptive, observational, analytical type done in Department of Pathology at tertiary care hospital from May 2012 to April 2016. All cases clinically suspected of GTD were included and confirmation was done by histopathological study on H&E stained slides. The cases of GTD were classified according to WHO classification. Detailed histomorphological features and beta human Chorionic Gonadotropin (hCG) levels were correlated.
RESULTS: During study period, 18345 deliveries were reported; out of which 77 cases were diagnosed as GTD. Almost 97.40% cases were of hydatidiform moles, 1.30% cases of choriocarcinoma and 1.30% cases of Placental Site Trophoblastic Tumour (PSTT). Among the cases of hydatidiform mole 57.34% were complete mole and 41.33% cases were of partial mole. The common clinical presentation was per vaginal bleeding and amenorrhea. The blood group A was most commonly observed in patient (49.35%). In majority of cases beta hCG levels were between 50,000 to 100000 mIU/ml. The correlation between beta hCG level and GTD were done.
CONCLUSION: Pregnant females clinically presenting with abnormal vaginal bleeding must be evaluated for GTD. Histopathological examination is helpful for confirmatory diagnosis. Follow up of such patients is essential for early detection of malignant trophoblastic tumours.

Entities:  

Keywords:  Disorders; Hydatid mole; Pregnancy

Year:  2017        PMID: 28969138      PMCID: PMC5620778          DOI: 10.7860/JCDR/2017/27232.10458

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  15 in total

Review 1.  Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole.

Authors:  John R Lurain
Journal:  Am J Obstet Gynecol       Date:  2010-08-21       Impact factor: 8.661

2.  [Survey of gestational trophoblastic disease incidence among 3.6 million pregnancies in China].

Authors:  Yi-fu Shi; Juan-qing Li; Wei Zheng; Xue-jun Chen; Yu-huan Qiao; Min Hao; Chong-wan Zhou; Ya-li Hu; Gui-mei Wan; Yu-cheng Sha; Xiu Zheng
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2005-02

Review 3.  Gestational trophoblastic disease.

Authors:  Michael J Seckl; Neil J Sebire; Ross S Berkowitz
Journal:  Lancet       Date:  2010-07-29       Impact factor: 79.321

4.  The demographics of molar pregnancies in BPKIHS.

Authors:  A Koirala; P Khatiwada; A Giri; P Kandel; M Regmi; D Upreti
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2011 Oct-Dec

Review 5.  Advances in the epidemiology of gestational trophoblastic disease.

Authors:  J R Palmer
Journal:  J Reprod Med       Date:  1994-03       Impact factor: 0.142

6.  Epidemiology of gestational trophoblastic neoplasm at the Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia.

Authors:  M F Aziz; N Kampono; E M Moegni; S Sjamsuddin; B Barnas; R S Samil
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

7.  Pure choriocarcinoma of ovary diagnosed by fine needle aspiration cytology.

Authors:  M R Naniwadekar; S R Desai; N S Kshirsagar; N N Angarkar; V D Dombale; S V Jagtap
Journal:  Indian J Pathol Microbiol       Date:  2009 Jul-Sep       Impact factor: 0.740

8.  Choriocarcinoma incidence in the United States.

Authors:  L A Brinton; M B Bracken; R R Connelly
Journal:  Am J Epidemiol       Date:  1986-06       Impact factor: 4.897

9.  ABO blood-groups and the risk of gestational trophoblastic disease.

Authors:  F Parazzini; C La Vecchia; S Franceschi; S Pampallona; A Decarli; G Mangili; C Belloni
Journal:  Tumori       Date:  1985-04-30

10.  Clinico-epidemiological profile of molar pregnancies in a tertiary care centre of Eastern Nepal: a retrospective review of medical records.

Authors:  Nimisha Agrawal; Reshu Agrawal Sagtani; Shyam Sundar Budhathoki; Hanoon P Pokharel
Journal:  Gynecol Oncol Res Pract       Date:  2015-10-31
View more
  7 in total

1.  A case of unplanned pregnancy at 2 months after uterine curettage in a patient with a hydatidiform mole.

Authors:  Jie-Qiong Cao; Ye Zhao; Ying Ma; Qiu-Man Wang; Li-Na Niu; Si Qiao
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

2.  An invasive mole with pulmonary metastases in a 55-year-old postmenopausal Syrian woman: a case report and review of the literature.

Authors:  Sawsan Ismail; Karen Mikhael; Nehad Salloum; Zuheir Alshehabi
Journal:  J Med Case Rep       Date:  2021-01-18

3.  Early Detection of Gestational Trophoblastic Neoplasia Based on Serial Measurement of Human Chorionic Gonadotrophin Hormone in Women with Molar Pregnancy.

Authors:  Roya Riahi; Abbas Rahimiforoushani; Keramat Nourijelyani; Nooshin Akbari Sharak; Mahmood Bakhtiyari
Journal:  Int J Prev Med       Date:  2020-12-11

4.  miR-30a targets STOX2 to increase cell proliferation and metastasis in hydatidiform moles via ERK, AKT, and P38 signaling pathways.

Authors:  Zhenzhen Guo; Chenyu Zhu; Ying Kong; Dong Li; Linlin Sui; Youhui Wang; Zhen Li; Lu Wang; Jianhui Fan; Yuefei Xu; Na Zou
Journal:  Cancer Cell Int       Date:  2022-03-04       Impact factor: 5.722

5.  Ten-Year Review of Gestational Trophoblastic Disease at Lady Reading Hospital, Peshawar.

Authors:  Shahzadi S Hussain; Mehnaz Raees; Rehana Rahim
Journal:  Cureus       Date:  2022-07-06

6.  Progesterone limits the tumor-promoting effects of the beta-subunit of human chorionic gonadotropin via non-nuclear receptors.

Authors:  Moumita Sarkar; Harsh Sharma; Parminder Singh; Ranbala Ranu; Ravi Datta Sharma; Usha Agrawal; Rahul Pal
Journal:  iScience       Date:  2022-06-03

7.  Invasive mole in a perimenopausal woman with lung and vaginal metastases: A case report.

Authors:  Cristina Martínez Leocadio; José García Villayzán; Jesús García-Foncillas López; Franklin Idrovo; Javier Plaza Arranz; Manuel Albi González
Journal:  Clin Case Rep       Date:  2019-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.